Cholera vaccine live attenuated

Drug Profile

Cholera vaccine live attenuated

Latest Information Update: 27 Nov 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Harvard Medical School; International Centre for Diarrhoeal Disease Research
  • Developer Harvard Medical School; International Centre for Diarrhoeal Disease Research; Walter Reed Army Institute of Research
  • Class Attenuated vaccines; Cholera vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cholera

Most Recent Events

  • 27 Nov 2006 Discontinued - Preclinical for Cholera in Bangladesh (unspecified route)
  • 27 Nov 2006 Discontinued for Cholera in USA (unspecified route)
  • 25 Jun 2001 No-Development-Reported for Cholera in Bangladesh (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top